Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV
申请人:Sanofi-Aventis Deutschland GmbH
公开号:US08236810B2
公开(公告)日:2012-08-07
The invention 8-aminothioxanthines and the derivatives of formula I
wherein the various R groups and substituents are comprised of a number of different (C1-C10)-alkyl, cycloalkyl, aryl, alkene, alkyne, etc. groups and derivatives thereof which are hereinafter more specifically defined for the treatment of metabolic disorders such as type-2 diabetes, hyperglycemia, arteriosclerotic diseases and the like.
该发明涉及8-氨基硫代黄嘌呤和式I的衍生物,其中各种R基团和取代基由许多不同的(C1-C10)-烷基,环烷基,芳基,烯烃,炔烃等基团和衍生物组成,这些基团和衍生物在此后更具体地定义,用于治疗代谢性疾病,如2型糖尿病,高血糖,动脉硬化疾病等。